跳至主要内容
临床试验/NCT02639988
NCT02639988终止不适用

Impact of Rheumatoid Arthritis on Type 2 Diabetes Mellitus

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 176 人开始时间: 2016年4月13日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
176
试验地点
1
主要终点
Time to the addition of a new treatment for type 2 diabetes in months

研究概览

简要总结

The purpose of this study is to determine whether patients with rheumatoid arthritis and type 2 diabetes experience a more severe disease course compared to control patients with osteoarthritis and type 2 diabetes

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (>18 years)
  • Rheumatoid arthritis fulfilling American College of Rheumatology (ACR )1987 or European League Against Rheumatism (ACR/EULAR) 2010 classification criteria
  • Type 2 diabetes (HbA1c ≥6.5% OR fasting glycemia≥7 mmol/l OR glycemia 120 min after 75 mg glucose ingestion ≥ 11.1 mmol/l OR symptoms of hyperglycemia with glycemia ≥11.1 mmol/l)
  • Affiliated to social security system
  • Adults (>18 years) matched for age, sex and BMI with patients with rheumatoid arthritis
  • Osteoarthritis (knee, hip, spine and hand)
  • Type 2 diabetes with disease duration matched with patients with rheumatoid arthritis
  • Affiliated to social security system

排除标准

  • Patient not able to understand study implication and rules
  • Patient opposed to participate to the study
  • Transient diabetes
  • Gestational diabetes
  • Secondary diabetes

结局指标

主要结局

Time to the addition of a new treatment for type 2 diabetes in months

时间窗: five years

addition of a new treatment includes insulin requirement

次要结局

  • Proportion of patients requiring the addition of a new treatment for type 2 diabetes in %(five years)
  • Proportion of patients with type 2 diabetes-related acute complications in %(two years)
  • Glycated haemoglobin (HbA1c) levels in %(two years)
  • Insulin resistance (HOMA-IR), absolute value(two years)
  • Proportion of patients requesting insulin in %(two years)
  • Proportion of patients with increased glycated haemoglobin (HbA1c) levels between 2 visits in %(five years)
  • Proportion of patients with increased HOMA-IR between 2 visits in %(five years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验